结直肠癌组织中COL1A1、miR-143的表达水平和临床意义以及两者的相关性
The Expression Levels, Clinical Significance, and Correlation of COL1A1 and miR-143 in Colorectal Cancer Tissues
DOI: 10.12677/acm.2024.14123047, PDF,    科研立项经费支持
作者: 程 伟, 田 畅, 陶 伦, 罗晓红, 舒武英*:大理大学临床医学院,云南 大理
关键词: 结直肠癌COL1A1miR-143临床意义Colorectal Cancer COL1A1 miR-143 Clinical Significance
摘要: 目的:探讨COL1A1和miR-143在结直肠癌中的表达水平和临床意义以及两者的相关性。方法:收集80例结直肠癌患者的组织蜡块和50例结直肠癌患者的新鲜标本,分别用IHC和qRT-PCR检测COL1A1和miR-143的表达水平,并利用统计学方法分析两者表达水平的相关性及与患者临床病理参数的关系。结果:在结直肠癌组织中,COL1A1的表达高于癌旁组织(P < 0.001),miR-143的表达低于癌旁组织(P < 0.001),两者的相对表达量呈显著负相关且都与肿瘤直径、分化程度、淋巴结转移、TNM分期相关(P值 < 0.05);结论:1) 在结直肠癌组织中,COL1A1的表达升高,miR-143的表达降低,且miR-143表达低时,COL1A1mRNA表达高,反之亦然;2) 两者表达水平都与肿瘤的直径、分化程度、淋巴结转移和TNM分期相关。
Abstract: Objective: To investigate the expression level and clinical significance of COL1A1 and miR-143 in colorectal cancer and their correlation. Methods: Collect tissue wax blocks from 80 patients with colorectal cancer and fresh specimens from 50 patients with colorectal cancer. The expression levels of COL1A1 and miR-143 were detected by IHC and qRT-PCR, respectively, and the correlation between the expression levels of the two genes and their relationship with clinical pathological parameters were analyzed using statistical methods. Results: In colorectal cancer tissues, the expression of COL1A1 was higher than that of adjacent tissues (P < 0.001), and the expression of miR-143 was lower than that of adjacent tissues (P < 0.001). The relative expression levels of the two were significantly negatively correlated. All are related to tumor diameter, degree of differentiation, lymph node metastasis, TNM staging (P value < 0.05); Conclusion: 1) In colorectal cancer tissues, the expression of COL1A1 increases, the expression of miR-143 decreases, and when the expression of miR-143 is low, COL1A1mRNA expression is high, and vice versa; 2) Both expression levels are related to tumor diameter, degree of differentiation, lymph node metastasis and TNM stage.
文章引用:程伟, 田畅, 陶伦, 罗晓红, 舒武英. 结直肠癌组织中COL1A1、miR-143的表达水平和临床意义以及两者的相关性[J]. 临床医学进展, 2024, 14(12): 56-65. https://doi.org/10.12677/acm.2024.14123047

参考文献

[1] Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R.L., Torre, L.A. and Jemal, A. (2018) Global Cancer Statistics 2018: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 68, 394-424. [Google Scholar] [CrossRef] [PubMed]
[2] 吴春晓, 顾凯, 龚杨明, 郑荣寿, 王少明, 陈茹, 张思维, 施燕, 魏文强, 付晨, 赫捷. 2015年中国结直肠癌发病和死亡情况分析[J]. 中国癌症杂志, 2020, 30(4): 241-245.
[3] 陈万青, 孙可欣, 郑荣寿, 张思维, 曾红梅, 邹小农, 赫捷. 2014年中国分地区恶性肿瘤发病和死亡分析[J]. 中国肿瘤, 2018, 27(1): 1-14.
[4] 杜灵彬, 李辉章, 王悠清, 朱陈, 郑荣寿, 张思维, 陈万青, 赫捷. 2013年中国结直肠癌发病与死亡分析[J]. 中华肿瘤杂志, 2017, 39(9): 701-706.
[5] 郑荣寿, 孙可欣, 张思维, 等. 2015年中国恶性肿瘤流行情况分析[J]. 中华肿瘤杂志, 2019, 41(1): 19-28.
[6] Michael Michael, Z., O’Connor Susan, M., van Holst Pellekaan Nicholas, G., Young Graeme, P. and James Robert, J. (2003) Reduced Accumulation of Specific microRNAs in Colorectal Neoplasia. Molecular Cancer Research, 1, 882-891.
[7] Sahami-Fard, M.H., Kheirandish, S. and Sheikhha, M.H. (2019) Expression Levels of miR-143-3p and-424-5p in Colorectal Cancer and Their Clinical Significance. Cancer Biomarkers, 24, 291-297. [Google Scholar] [CrossRef] [PubMed]
[8] Qian, X., Yu, J., Yin, Y., He, J., Wang, L., Li, Q., et al. (2013) microRNA-143 Inhibits Tumor Growth and Angiogenesis and Sensitizes Chemosensitivity to Oxaliplatin in Colorectal Cancers. Cell Cycle, 12, 1385-1394. [Google Scholar] [CrossRef] [PubMed]
[9] Chen, X., Guo, X., Zhang, H., Xiang, Y., Chen, J., Yin, Y., et al. (2009) Role of miR-143 Targeting KRAS in Colorectal Tumorigenesis. Oncogene, 28, 1385-1392. [Google Scholar] [CrossRef] [PubMed]
[10] Guo, L., Fu, J., Sun, S., Zhu, M., Zhang, L., Niu, H., et al. (2019) MicroRNA‐143‐3p Inhibits Colorectal Cancer Metastases by Targeting ITGA6 and ASAP3. Cancer Science, 110, 805-816. [Google Scholar] [CrossRef] [PubMed]
[11] Maasalu, K., Nikopensius, T., Kõks, S., Nõukas, M., Kals, M., Prans, E., et al. (2015) Whole-Exome Sequencing Identifies De Novo Mutation in the COL1A1 Gene to Underlie the Severe Osteogenesis Imperfecta. Human Genomics, 9, Article No. 6. [Google Scholar] [CrossRef] [PubMed]
[12] Brooks, M., Mo, Q., Krasnow, R., Ho, P.L., Lee, Y., Xiao, J., et al. (2016) Positive Association of Collagen Type I with Non-Muscle Invasive Bladder Cancer Progression. Oncotarget, 7, 82609-82619. [Google Scholar] [CrossRef] [PubMed]
[13] Willis, C.M. and Klüppel, M. (2014) Chondroitin Sulfate-E Is a Negative Regulator of a Pro-Tumorigenic WNT/β-Catenin-Collagen 1 Axis in Breast Cancer Cells. PLOS ONE, 9, e103966. [Google Scholar] [CrossRef] [PubMed]
[14] Song, Y., Kim, S., Kim, K.M., Choi, E.K., Kim, J. and Seo, H.R. (2016) Activated Hepatic Stellate Cells Play Pivotal Roles in Hepatocellular Carcinoma Cell Chemoresistance and Migration in Multicellular Tumor Spheroids. Scientific Reports, 6, Article No. 36750. [Google Scholar] [CrossRef] [PubMed]
[15] Zeng, Y., Liu, J., Yan, Z., Yao, X. and Liu, X. (2015) Potential MicroRNA Biomarkers for Acute Ischemic Stroke. International Journal of Molecular Medicine, 36, 1639-1647. [Google Scholar] [CrossRef] [PubMed]
[16] Rai, A., Greening, D.W., Chen, M., Xu, R., Ji, H. and Simpson, R.J. (2019) Exosomes Derived from Human Primary and Metastatic Colorectal Cancer Cells Contribute to Functional Heterogeneity of Activated Fibroblasts by Reprogramming Their Proteome. PROTEOMICS, 19, Article ID: 1800148. [Google Scholar] [CrossRef] [PubMed]
[17] Mori, K., Enokida, H., Kagara, I., Kawakami, K., Nishiyama, K., Kawahara, K., et al. (2009) CPG Hypermethylation of COL1A2 Contributes to Proliferation and Migration Activity of Bladder Cancer. Journal of Urology, 181, 309. [Google Scholar] [CrossRef
[18] Liu, J., Shen, J.X., Wu, H.T., Li, X.L., Wen, X.F., Du, C.W. and Zhang, G.J. (2018) Collagen 1A1 (COL1A1) Promotes Metastasis of Breast Cancer and Is a Potential Therapeutic Target. Discovery Medicine, 25, 211-223.
[19] Wang, Q. and Yu, J. (2018) MiR-129-5p Suppresses Gastric Cancer Cell Invasion and Proliferation by Inhibiting COL1A1. Biochemistry and Cell Biology, 96, 19-25. [Google Scholar] [CrossRef] [PubMed]
[20] He, B., Lin, X., Tian, F., Yu, W. and Qiao, B. (2017) MiR‐133a‐3p Inhibits Oral Squamous Cell Carcinoma (OSCC) Proliferation and Invasion by Suppressing COL1A1. Journal of Cellular Biochemistry, 119, 338-346. [Google Scholar] [CrossRef] [PubMed]
[21] Guo, L., Fu, J., Sun, S., Zhu, M., Zhang, L., Niu, H., et al. (2019) MicroRNA‐143‐3p Inhibits Colorectal Cancer Metastases by Targeting ITGA6 and ASAP3. Cancer Science, 110, 805-816. [Google Scholar] [CrossRef] [PubMed]
[22] Pekow, J., Meckel, K., Dougherty, U., Butun, F., Mustafi, R., Lim, J., et al. (2015) Tumor Suppressors MiR-143 and MiR-145 and Predicted Target Proteins API5, ERK5, K-RAS, and IRS-1 Are Differentially Expressed in Proximal and Distal Colon. American Journal of Physiology-Gastrointestinal and Liver Physiology, 308, G179-G187. [Google Scholar] [CrossRef] [PubMed]